Skip to main content
GRML
NASDAQ Life Sciences

Greenland Mines Issues 12.4M Shares for 9.9% Stake in AnorTech Inc.

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.268
Mkt Cap
$32.492M
52W Low
$0.21
52W High
$1.67
52W Position info
28% above low
Off High info
84% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

GRML sits 28% above its 52-week low of $0.21.

Summary

Greenland Mines exchanged 12.4 million of its shares for a 9.9% stake in AnorTech Inc. and secured an option for further acquisition, marking a significant strategic investment.


Key Events · M&A and Partnerships · GRML

  • Strategic Equity Acquisition

    Greenland Mines acquired 19,958,503 common shares of AnorTech Inc., representing a 9.9% stake in the TSXV-listed company.

  • Significant Share Issuance

    The company issued 12,400,000 common shares, valued at approximately $3.32 million, to AnorTech as consideration. This represents over 10% dilution to existing shareholders.

  • Future Acquisition Option

    Greenland Mines secured a six-month option to acquire an additional 25,168,669 AnorTech shares, with the exercise price payable in Greenland Mines stock.

  • Long-Term Lock-Up

    Shares exchanged are subject to lock-up periods of 12, 24, and 60 months, indicating a long-term strategic intent for the investment.


Analysis · GRML · Life Sciences

Greenland Mines Ltd. has issued 12.4 million common shares, representing over 10% dilution, to acquire a 9.9% equity stake in AnorTech Inc., a TSXV-listed company. This strategic investment, valued at approximately $3.32 million based on current share price, also includes an option to acquire an additional 25.17 million AnorTech shares. The transaction uses Greenland Mines' stock as currency, which is significant given the company's ongoing financial challenges, recent shareholder approval for a reverse stock split, and previous dilutive offerings.

At the time of this filing, GRML was trading at $0.27 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $32.5M. The 52-week trading range was $0.21 to $1.67. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GRML - Latest Insights

GRML
Jul 28, 2026, 12:37 PM EDT
Source: FinanceWire
Importance Score:
7
Price at Filing: $0.190
Real-time Price: $0.1755 info
Change: -$0.0145 (-8%) info
Market Cap: $28.023M info
GRML
Jul 27, 2026, 2:11 PM EDT
Source: FinanceWire
Importance Score:
7
Price at Filing: $0.179
Real-time Price: $0.1755 info
Change: -$0.0035 (-2%) info
Market Cap: $28.023M info
GRML
Jul 23, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.228
Real-time Price: $0.1755 info
Change: -$0.0525 (-23%) info
Market Cap: $28.023M info
GRML
Jul 20, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.190
Real-time Price: $0.1755 info
Change: -$0.0145 (-8%) info
Market Cap: $28.023M info
GRML
Jul 17, 2026, 11:12 AM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $0.184
Real-time Price: $0.1755 info
Change: -$0.0085 (-5%) info
Market Cap: $28.023M info